The U.S. Just Signed A $450 Million Coronavirus Vaccine Contract With Johnson & Johnson

31 Mar, 2020

The Trump administration is spending nearly half a billion dollars on one company in the race to find a coronavirus vaccine.


That’s according to a $456 million order with Johnson & Johnson’s Pharmaceuticals arm Janssen, which specified a “new vaccine asset for 2019 Novel Coronavirus (COVID-19),” Forbes found. It’s the largest reported amount spent on a vaccine project to date, even though the pharma giant hasn’t yet started any clinical trials as other firms have.


Click here for reference